Delaney Brendan 4
4 · IMMUNOMEDICS INC · Filed Oct 23, 2020
Insider Transaction Report
Form 4
IMMUNOMEDICS INCIMMU
Delaney Brendan
Chief Commercial Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2020-10-23−390,460→ 0 total→ Common Stock (390,460 underlying)
Footnotes (1)
- [F1]In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock ("Stock Option") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration.